|Day Low/High||109.74 / 112.65|
|52 Wk Low/High||73.69 / 116.61|
A split Congress is the best-case scenario for the drug industry, several analysts said.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AES, ALIM, APPS, EXAS, INVH, LBRDA, LBRDK, LLY, TLK Downgrades: CTT, DRH, HA, MTDR, ORIT, RNG Initiations: None Read on to get TheStreet Quant Ratings' detailed report:
Eli Lilly's excellent earnings weren't excellent enough.
The Dow and S&P 500 are posting modest gains on Tuesday as voters head to the polls for the U.S. midterm elections.
Eli Lilly's self-policing on drug pricing protects it from the most prominent political pushbacks.
Eli Lilly's confirmation of acquisition action could make pharmaceuticals an attractive investment space.
Eli Lilly posted stronger-than-expected third quarter earnings Tuesday, and boosted its 2018 profit guidance for the second consecutive time this year as its diabetes drug franchise continues to add to the group's bottom line.
LLY's stock slide after earnings might present a buying opportunity.
A bunch of pot stocks are in play on Tuesday -- for a reason.
The giant drugmaker raised its profit guidance for all of 2018 after its third-quarter results beat expectations.
It shouldn't hurt that the drugmaker beat third-quarter estimates and raised its profit guidance for all of 2018.
U.S. stock futures are lower on Tuesday as Wall Street's focus turns to the midterm elections; Eli Lilly and CVS Health report earnings; Amazon reportedly to split its second headquarters in two locations; Under Armour says will accelerate a culture change following a report about workplace misconduct.
Global stocks steadied Tuesday, even as interest rates crept higher and the dollar regained its composure against rival currencies, with investors unambiguously focused on the outcome of midterm elections later today that could either stall or extend the longest equity bull market in history.
- Third-quarter 2018 revenue increased 7 percent, driven primarily by increased demand for new medicines, while operating expenses increased 1 percent.
Insiders buy for only one reason -- to make money.
INDIANAPOLIS and BELTSVILLE, Md., Nov.
Only 31 percent of REWIND trial participants had established CV disease
- Jardiance (empagliflozin) was associated with a 44 percent reduction in relative risk of hospitalization for heart failure (HHF) compared with commonly used dipeptidyl peptidase-4 inhibitors
Once the safest stocks in the book, the big-cap drug companies are now toxic.
- Companies will collaborate on RNAi research for cardio-metabolic, neurodegeneration and pain targets
LLY has made a good run this year and now looks like it will correct a bit.
This is serious: The market is ignoring legitimate, positive earnings, says Jim Cramer, and tariffs and rates are the culprits.
Jim Cramer is ready to call the Fed out. And he has your game plan ready for next week.
Jim Cramer weighs in on GoPro, Eli Lilly, HealthEquity, General Mills, and Marriott International.
Jim Cramer says it'll be hard for stocks to stabilize until the Fed's stance softens. He's got your game plan for next week.
Jim Cramer says traders hate hearing about long-term investing because they want instant payoffs.
There is clear divergence between the best and the worst performers in each sector this earnings season.
Pfizer Inc. (NYSE:PFE) and Eli Lilly and Company (NYSE:LLY) today announced complete results from a Phase 3 study evaluating the efficacy and safety of subcutaneous administration of tanezumab, an investigational humanized monoclonal antibody, in patients...
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.